University of Florida College of Medicine
Conflict of Interest Disclosure

The 27th Annual Multidisciplinary Symposium on Breast Disease

It is the policy of the University of Florida College of Medicine to ensure balance, independence, objectivity, and scientific rigor in all programs it provides. In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Integrity and Independence in Accredited Continuing Education, the University of Florida College of Medicine is required to disclose to the activity audience the relevant financial relationships of all persons involved in the selection, development, and presentation of CME content. Persons who refuse or fail to disclose conflicts of interest are disqualified from participating in the CME activity.

All conflicts of interest have been resolved prior to the educational activity through one of the following mechanisms:

  • altering the financial relationship with the commercial interest
  • altering the individual’s control over CME content about the products or services of the commercial interest
  • validating the activity content through independent peer review.

Relevant financial relationships appear below.

The following speakers and planning committee members have an affiliation/financial interest in the following areas:

  • Abigail S. Caudle, MD – receives Research Support from EndoMag at her institution.
  • Emily F. Conant, MD – receives Research support from Hologic, Inc and iCAD, Inc.; Is a Consultant for Hologic, Inc. and iCAD, Inc.; and is on the Speaker Burea for Aunt Minnie, and Medscape.
  • Kent K. Higdon, MD – is an Advisor for True Digital Surgery (microsurgery robotics) – no speaking roles, ownership or stock.
  • Anthony M Magliocco, MD – receives Research from Roche; Is a Consultant for Roche, Lilly, Astrazenica, BMS, Merck; Is a Speaker for BMS; Is a Stock Shareholder with Protean BioDiagnostics (also Director) and receives Salary and Shares from Protean BioDiagnostics.
  • Paul Okunieff, MD – receives Research Support from DiaCarta, Entrinsic Health and GainPep; is a Consultant for DiaCarta, Entrinsic Health and GainPep and is a Stock Sharehoulder with DiaCarta, Entrinsic Health and GainPep.
  • Jorge S. Reis-Filho, MD – is a Consultant for Goldman Sachs, Paige.AI, Repare Therapeutics, and Eli Lilly; is a Stock Shareholder with Paige.AI, Grupo Oncolinicas Brazil; and is a Member of the board of directors with Grupo Oncolinicas Brazil.  
  • Charles Shapiro, MD – is a Consultant for 2nd MD and receives Royalties from Uptodate.
  • Mylin Torres, MD – received Research Support from NIH, Pfizer, Genetech and V Foundation; is a Consultant for Oncology Analytics; and is a Speaker for Prime Oncology.
  • Debu Tripathy, MD – receives Research support from Novartis, Pfizer and Polyphor; and is a Consultant for Gilead, Novartis, Pfizer, GSK, OncoPep, AstraZeneca, Exact Sciences
  • Gary J. Whitman, MD – is a Consultant for Siemens; and is an Editor (Cambridge University Press) for UptoDate

The following speakers and planning committee members have no relevant financial relationships to disclose:

  • Julie A. Bradley, MD
  • Karen Earick
  • Armando E. Giuliano, MD
  • Heather Macdonald, MD
  • Shahla Masood, MD
  • Alexander S. Parker, MS, PhD
  • Freya Schnabel, MD
  • Lisa Spiguel, MD

Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure/. All relevant financial relationships listed have been mitigated.